Cite
HARVARD Citation
Askar, S. et al. (n.d.). 505. Bezlotoxumab Reduces Recurrence of Clostridium difficile Infection in Immunocompromised Patients: Early Experience at a Tertiary Care Center. Open forum infectious diseases. p. S187. [Online].